China NMPA Product Recall - ECG Management System

The National Medical Products Administration (NMPA) issued a public notice on September 23, 2014, concerning a voluntary recall initiated by Philips Medical Systems for its ECG Management System (Model 860426, Registration Certificate No.: CFDA (Imported) No. 20132700072). Philips (China) Investment Co., Ltd. formally reported this recall on September 17, 2014, referencing an internal report dated August 14, 2014. The core issue stemmed from a critical malfunction: when multiple Quinton Stress ECG records were processed concurrently using software option C61, a patient's XML identifier could be erroneously linked to another patient's report within the processing sequence. This defect could result in a single recovered record containing two distinct patient identifiers, posing a serious threat to patient data accuracy and safety. The problem was confirmed not to occur if Stress ECG records were output individually after each test. Philips stated that the specific affected product batches were not sold or imported into the Chinese market. As a regulatory action, the NMPA instructed all provincial food and drug administration departments to oversee and manage such products, irrespective of their local distribution status, underscoring the broad reach of regulatory vigilance in ensuring medical device safety and data integrity.